Labcorp Holdings Inc. (FRA:N6B)

Market Cap	19.33B
Revenue (ttm)	11.48B
Net Income (ttm)	650.04M
Shares Out	n/a
EPS (ttm)	7.72
PE Ratio	29.74
Forward PE	16.16
Dividend	2.66 (1.17%)
Ex-Dividend Date	May 29, 2025

Volume	n/a
Average Volume	61
Open	228.00
Previous Close	226.00
Day's Range	228.00 - 228.00
52-Week Range	183.00 - 240.00
Beta	n/a
RSI	60.09
Earnings Date	Jul 24, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical Laboratories
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N6B

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD